Clinical Trial Update: A Study to Evaluate the Safety and Efficacy of Subcutaneously Administered REGN475(SAR164877) in Patients With Sciatic Pain [Phase 2]

View source ↗

Summary

This update reports the completion of a Phase 2 trial evaluating the safety and efficacy of subcutaneously administered REGN475 (SAR164877) in patients with sci…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sciatica

Drugs mentioned

• REGN475 (SAR164877) (SAR164877)

Snippet

Sponsor: Regeneron Pharmaceuticals | Conditions: Sciatica | Phase 2 | Status: COMPLETED